#AACR25 honored 9 outstanding cancer journalists. Only 1 winner could not make it to the stage because of the war. @Rashaaboujalal1 has been reporting on breast cancer patients who have no access to medication or even painkiller. Read her report here https://t.co/dPqOGlyA2o

Excited to be at #AACR25 @ Chicago! Looking forward to connecting with colleagues, collaborators, and friends. If you're around, say hello!

Is chatGPT down? @OpenAI

New research from @DanaFarber’s David Liu & Giuseppe Tarantino in @ScienceAdvances shows new machine-learning technique can predict which melanoma patients are likely to fare poorly with single-agent therapy and might benefit from combination therapy. ➡️ https://t.co/4Qi3rGFnRu

From someone from whom I took my first neural network course.😍👇

I am happy to announce that MIT Press will soon make a second printing of my book "Probabilistic ML: An Intro". I have uploaded the latest version to https://t.co/DVdjXzkljm. This fixes over 100 github issues - thanks for all the feedback!

Excited to share that we have another fully funded opening for a postdoc in computational cancer genomics @Bos_CHIP @harvardmed. We will start evaluating applications in Dec on a rolling basis. Please email me with questions and check here more details

Here's our latest - a deep dive into noncoding mutations in cancer - led by @FelixDietlein (starting his own lab! https://t.co/SVgPRY0HVE), with @JamesTneal @alexb_wang @ecuppen Dr. Sunyaev et al @DanaFarber @broadinstitute @ScienceMagazine👇

We're hiring! We need a postdoc to help us apply ML and advanced analytics to EHR data to improve cancer research and care at Dana-Farber and beyond. Please take a look:

Please consider supporting cancer research @DanaFarber @DanaFarberNews + the extraordinary interdisciplinary science happening in Population Sciences through our @PanMass PopSciCycles team! https://t.co/Bmzrz4Xwms

Officially settling in here @YaleCancer @YaleMed, and I am grateful for the warm welcome! If you are interested in cancer immunotherapy, translational research, genomics, or kidney cancer, please contact me (david.braun@yale.edu). We are hiring at all levels (postgrad, MS, PhD)!

Happy to share our work using NLP to extract clinical outcomes from the EHR for linkage to cancer genomic data: https://t.co/mOfxen3Z7Q . Thanks to coauthors @VincentWenxinXu, Sasha Gusev, @ZiadBakouny, @DrChoueiri, Haitham Elmarakeby, Irbaz Riaz, @VanAllenLab, and Deb Schrag!

For all of your edgy machine learning needs!

For the first time, the @US_FDA has approved an #immunotherapy drug given after surgery for certain patients with #kidneycancer. The approval of adjuvant pembrolizumab was based on clinical testing led by Dana-Farber's Toni Choueiri, MD (@DrChoueiri): https://t.co/VxFB16NUN8

Good news. This will help. This pill for 5 days reduced hospitalizations and deaths by 89%, from 8 to 0.7%

Come do a postdoc in ML and stats @MSRNE! We're especially open to candidates who overlap with our interests in healthcare, computational biology, economics, human-computer interaction, social media, cryptography, and mathematics https://t.co/UUPJI0RXKz

Published today in @naturemethods together with colleagues from @calico: Enformer - a transformer model that has led to greatly increased accuracy in predicting gene expression from DNA sequence. Blog: https://t.co/21zIewaiKR Paper: https://t.co/Bg1gPp4AWe 1/

Today is #WorldCancerResearchDay. The AACR is proud to work with organizations and individuals around the world to advance cancer science. We are excited to be part of this global initiative to propel progress against cancer. Learn more: https://t.co/w0Ka8m9R4t #ResearchWorks

We regret to inform you…

Hello! I'm recruiting students interested in ML/data science, especially as applied to healthcare or inequality. If this is you, please consider applying to 1) MSR internship ( https://t.co/ze7ahV0I6b - for current PhD students) and 2) Cornell CS PhD. Please RT.